Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

NCT01671683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2012-08-23

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of additional neoadjuvant chemotherapy with capecitabine during the resting periods in patients with locally advanced rectal cancer.

Conditions

Sponsors & Collaborators

  • Chungnam National University

    lead OTHER

Principal Investigators

  • Ji Yeon Kim, MD., PhD · Surgical Oncology Research Lab

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Completion
2011-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01671683 on ClinicalTrials.gov